Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall baycolBaycol cholesterol drug was introduced to the market as a newer statin drug and was seen to be both effective and safe. Soon, Baycol adverse effect reports and Baycol deaths were being reported amongst Baycol users. All statin drugs had been linked to the rare side effect rhabdomyolysis, but Baycol deaths and incidence because of it were being reported at a much higher rate than amongst other statin drugs.
In August 2001, after reports of 52 Baycol deaths and 416 cases of rhabdomyolysis, Baycol was recalled. It was later discovered that over 100 Baycol deaths had occurred. What followed the reports of Baycol death and adverse effects and the announcement of the Baycol recall were a large number of Baycol lawsuits that have left a lasting impact on the way drug companies, insurers, and consumers view the industry. People began to file claims in large numbers because of the Baycol deaths and potentially fatal adverse effects.
Bayer said that it had paid out $477 million to settle out of court 1,342 Baycol cases in the U.S. as of August 2003 and still faces 11,000 Baycol cases for Baycol death and side effects. The company has said that it would continue to evaluate each individual case and based on its seriousness, such as a Baycol death or serious rhabdomyolysis appropriately try to resume it.
An editorial in the Journal of the American Medical Association is one of just several articles to appear in next week’s edition that focuses on the FDA’s ability to effectively monitor drug safety. Following the September Vioxx recall, more critics h...
Bayer''s Baycol cholesterol drug was recalled in August 2001 and is now linked to over 100 deaths. The company has so far paid $842 million to settle 2,224 cases but still faces 9,948 more Baycol cases. Now the company is facing a class action in Penns...